Skip to main content
  1. Home
  2. Emerging Tech
  3. Outdoors
  4. News

Have a need for speed? Check out the Draco drone from Uvify

Add as a preferred source on Google

Your need for speed is about to be satisfied.

The Draco drone from Uvify will go 100 miles per hour, and yes, you can actually buy it. So when Uvify says at CES that it’s looking to transform the way humans fly, this is what it’s talking about — a supercharged drone that will zoom through the air at alarming speeds.

Recommended Videos

With an employee base comprised of actual rocket scientists, Uvify is at the forefront of modern drone technology, and has made good on its promise to deliver “lightweight, lightning-fast drones that are easy to use, modify, and repair.” The Draco weighs in at just over a pound when it’s empty, and measures just 8.4 by 6.5 inches. But its diminutive size allows it to hit pretty impressive speeds. Powered by a Uvify Direct-Drive 3-Phase Brushless DC Motor, the Draco’s power tops out at 580 watts, and boasts a 26,000 max RPM.

Capable of a 360-degree flip, the Draco will let the most experienced of drone pilots show off a bit with some tricks, even at high speeds. In fact, Uvify says that its new drone will allow you not only to race, but freestyle fly, stunt fly, carry out visual aerial exhibitions, as well as conduct extreme aerial photography. But don’t worry — if you crash the drone, its modular design means that you can replace broken parts easily without having to buy a whole new machine. That said, when you first receive Draco, you won’t have to put it together. It comes completely ready to fly, straight out of the box.

While the drone is designed to withstand even the most inclement of weather (which means you can take some pretty impressive photos of rainstorms with the 5.8Ghz video unit), it isn’t fully waterproof. That is to say, do not attempt to fly Draco underwater — it won’t work.

You can pre-order the Draco now for $499, and shipment is expected to begin in the second quarter of this year.

Lulu Chang
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more